Follow the ONCOSIL MEDICAL LTD share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €35.5m. The latest transaction was reported on 11 June 2026 (Change in Substantial Holding). Among the most active insiders: ABN 21 002 965 200. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ONCOSIL MEDICAL LTD es una empresa centrada en el desarrollo de tratamientos contra el cáncer, concentrándose en terapias innovadoras. Cotiza en el mercado XASX.